阿尔茨海默病中的髓病理:潜在的治疗机会
Zhihai Huang1, J Dedrick Jordan1, Quanguang Zhang1
1Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA 71103 USA.
Aging and disease
|August 7, 2023
概括
骨髓质变性,不仅仅是粉样质斑块,是阿尔茨海默病 (AD) 认知能力下降的关键因素. 针对髓修复提供了一个有前途的新治疗策略,用于AD.
科学领域:
- 神经科学是一个神经科学.
- 病理生理学 病理生理学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 阿尔茨海默病 (AD) 的特点是认知能力下降,但其病理生理学仍然不完全理解.
- 髓对神经元功能和记忆至关重要,在阿尔茨海默病中越来越被认为是脆弱的.
- 骨髓质变性可能在AD进展中先于粉样蛋白病理.
研究的目的:
- 审查髓在认知中的关键作用.
- 为了检查阿尔茨海默氏症进展中的髓病理.
- 探索针对AD中髓修复的治疗策略.
主要方法:
- 关于髓和AD的最近研究的文献综述.
- 对在阿尔茨海默氏症中髓退化背后的机制的分析.
- 讨论髓病理和AD病理生理学之间的相互作用.
主要成果:
- 髓在记忆巩固中起着至关重要的作用,在病理条件下是脆弱的.
- 髓退化是AD相关认知缺陷的重要贡献者.
- 髓病理可能独立于或之前发生粉样蛋白病理.
结论:
- 髓变性是阿尔茨海默病的一个关键病理生理特征.
- 准髓修复是一个有前途的治疗途径.
- 对髓作用的进一步研究可以推进阿尔茨海默症治疗策略.
相关概念视频
01:22Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
01:26Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521